Medicare patients who were at the highest risk of severe COVID-19 infections were less likely to get Paxlovid or other treatments, according to new research.
Health-care companies rose slightly, but incurred hefty losses for the week amid signs that greater patient uptake of discretionary medicine is weighing on.
With U.S. stock markets set to open in two hours, (RMD) was up 8.8% in pre-market trading, and (IBM) was up 7.2%. (RRC), (AAL), and (SFM) were all posting.